• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Pregnancy and Postpartum Course
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » Topics » Addiction Treatment

Addiction Treatment
Addiction Treatment RSS Feed RSS

Learning Objectives, Medical Issues in Addiction, CATR, April/May/June 2025

April 1, 2025
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

After reading these articles, you should be able to…


Read More
CATR_QA2_Joseph D'Orazio_headshot_sm.png
Expert Q&A

Xylazine and Peripheral Wounds

April 1, 2025
Joseph D’Orazio, MD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Joseph D’Orazio, MD, Associate Professor of Emergency Medicine, Cooper Medical School of Rowan University, Camden, NJ. Dr. D’Orazio has no financial relationships with companies related to this material.

Xylazine is a non-opioid sedative commonly added surreptitiously to illicit opioids. One particularly challenging adverse effect of xylazine exposure is the development of peripheral wounds, some of which can be severe, necessitating surgical intervention and even amputation. In this interview, Dr. D’Orazio teaches us how these wounds might be caused, how to discuss them with your patients, and the best treatment approach.


Read More
CATR_QA1_Aviv Ouanounou_Photo_sm.png
Expert Q&A

Substance Use and Dental Health: What Clinicians Need to Know

April 1, 2025
Aviv Ouanounou, DDS, MSc
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Aviv Ouanounou, DDS, MSc, Associate Professor, University of Toronto, Toronto, Canada. 

Dr. Ouanounou has no financial relationships with companies related to this material. 

Substance use is associated with many dental problems, some of which can even be life threatening. Here, Dr. Ouanounou discusses which specific dental issues addiction treatment providers need to be on the lookout for. He covers the basics of dental examination and teaches us when referral to specialty care is warranted.


Read More
Clinical Update

Understanding Viral Hepatitis in the Context of Addiction Psychiatry

April 1, 2025
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Danielle Herman. Case Western Reserve University School of Medicine, Cleveland, OH.

Raquel Rozner, MD. Gastroenterology Associates, PC, Stratford, CT; Bridgeport Hospital/Yale New Haven Health, Bridgeport, CT.

Akhil Anand, MD. Department of Psychiatry and Psychology, Cleveland Clinic; Department of Psychiatry, University Hospitals Medical Center, Cleveland, OH.

Ms. Herman, Dr. Rozner, and Dr. Anand have no financial relationships with companies related to this material. 

Hepatitis B and C are highly prevalent in people who use drugs and can result in significant morbidity and mortality due to progressive liver disease. In this article, we cover all the basics, including screening, symptoms, and relevant laboratory testing. We give tips to provide your patients on hepatitis prevention and when to refer them to specialists for treatment. 


Read More
Research Update

Long-Term Patient Outcomes with Buprenorphine for Opioid Use Disorder

January 1, 2025
Peter J. Farago, MD.
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Peter Farago, MD. Dr. Farago has no financial relationships with companies related to this material.

Researchers compare outcomes in patients who take buprenorphine for shorter and for longer. Their findings are revealing.


Read More
Research Update

Methamphetamine Withdrawal Treatment

January 1, 2025
Maryam Soltani, MD, PhD.
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Maryam Soltani, MD, PhD. Dr. Soltani has no financial relationships with companies related to this material.

While stimulant withdrawal typically does not cause physiologic symptoms requiring immediate medication treatment, patients can be behaviorally challenging during this time. Here, researchers developed a protocol to treat patients withdrawing from methamphetamines on an inpatient unit.

 


Read More
Expert Q&A

Navigating Cannabis Withdrawal

January 1, 2025
Alan J. Budney, PhD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

79F827C5-A00A-4EB7-A1CB-81C386F54350.jpegAlan J. Budney, PhD 

Professor of Psychiatry; Professor of Biomedical Data Science; Geisel School of Medicine at Dartmouth, Lebanon, NH.

Dr. Budney has served as a scientific advisor for Jazz Pharmaceuticals and Indivior Inc. Relevant financial relationships listed for the author have been mitigated.

Cannabis withdrawal is a largely underappreciated phenomenon that nonetheless interferes with many patients’ ability to stop using cannabis. Dr. Budney discusses some of the symptomatology of cannabis withdrawal and reviews how to discuss it with our patients.


Read More
932166E5-62E0-43E0-A69E-50E2F9ECBE7F.jpeg
Expert Q&A

Managing Withdrawal From Multiple Substances

January 1, 2025
Darius Rastegar, MD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

F77DAC3D-1C61-47C4-8BAB-51075F046EEA.jpegDarius Rastegar, MD 

Associate professor of medicine, Johns Hopkins University School of Medicine, Baltimore, MD. 

Dr. Rastegar has no financial relationships with companies related to this material.

Substance use disorders are highly comorbid with one another and it is therefore common to have patients presenting for care withdrawing from multiple substances at one time. Here, Dr. Rastegar discusses how to assess patients with multiple withdrawal syndromes and how to treat them.


Read More
Clinical Update

Effective Management of Buprenorphine-Precipitated Opioid Withdrawal

January 1, 2025
Jaewon Lee, MD, MPH
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Jaewon Lee, MD, MPH. PGY-2, psychiatry resident, University of Rochester Medical Center, Rochester, NY. 

Dr. Lee has no financial relationships with companies related to this material.

Buprenorphine is a first-line treatment for opioid use disorder, however, given buprenorphine to a patient who still has opioids in their system can precipitate severe withdrawal. Careful assessment of withdrawal can minimize the risk, but despite our best efforts, precipitated withdrawal can still occur. In this article, we review what to do for our patients experiencing buprenorphine-precipitated opioid withdrawal.


Read More
Clinical Update

Boost or Bust: Navigating the Risks of Prescription Stimulants

October 1, 2024
David Stiffler, MD and Noah Capurso, MD
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

David Stiffler, MD. Clinical Associate Professor of Psychiatry and Medical Director of the Steven A. Cohen Military Family Center at NYU Grossman School of Medicine, New York, NY.

Noah Capurso, MD, MHS. Associate Professor of Psychiatry, Yale University, and Editor-in-Chief, The Carlat Addiction Treatment Report.

Drs. Stiffler and Capurso have no financial relationships with companies related to this material.

Prescription stimulants, while effective for treating ADHD, are widely taken without a prescription, particularly by young adults for cognitive enhancement, weight loss, and recreational purposes. This misuse poses serious risks, from developing stimulant use disorder to experiencing severe cardiovascular and psychiatric effects. In this article, you'll learn about the prevalence and patterns of stimulant misuse, its associated dangers, and tips on how to manage it in clinical practice.


Read More
Previous 1 2 3 4 5 6 7 8 9 … 49 50 Next
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • OUDFB1e_Cover_Binding.png

    Treating Opioid Use Disorder—A Fact Book (2024)

    All the tools you need to assess and treat patients struggling with opioid use disorder. 
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2675415191.jpg
    General Psychiatry

    How to Start a Psych Medication IV

    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.